![Benedetta Pellegrino: Validation of the HRD RAD51 assay as a predictive biomarker for VUS pathogenicity in BRCA1](https://oncodaily.com/pub/uploads/2024/07/Benedetta-Pellegrino-f.png)
Photo taken from Benedetta Pellegrino/X
Jul 9, 2024, 22:15
Benedetta Pellegrino: Validation of the HRD RAD51 assay as a predictive biomarker for VUS pathogenicity in BRCA1
Benedetta Pellegrino, Resident in Medical Oncology at the University Hospital of Parma, shared on X:
“Discover our latest study on the validation of the HRD RAD51 assay as a predictive biomarker for VUS pathogenicity in BRCA1 in breast and ovarian cancer! ”
Read further.
Source: Benedetta Pellegrino/X
Jul 27, 2024, 19:56